Obese mice whose fat cells were genetically altered to produce an increased amount of the glucose-dependent insulinotropic ...

For this review, the authors searched for randomized controlled trials published in MEDLINE, Embase, and Cochrane CENTRAL ...

Professor Choi was recognized for his contribution to understanding how glucagon-like peptide-1 (GLP-1 ... a significant ...

New in vivo preclinical data announced today, demonstrate that icovamenib, in combination with semaglutide showed additional 11.5% body weight ...

These drugs, called glucagon-like peptide-1 receptor agonists (GLP-1 RAs), work in several different ways to help people lose ...

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

Other approaches that are in development include fibroblast growth factor (FGF) mimetics such as FGF21-targeting candidates ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...

Ready to crush your New Year’s health goals? These breakthrough medications offer more than weight loss—they support your ...

A patient came into the emergency department complaining about nausea, vomiting and abdominal pain. It was something more ...

Researchers have found that polyphenols cause the secretion of hormones that may help lower a risk of developing type 2 ...

These drugs, called glucagon-like peptide-1 receptor agonists ... “GLP-1 RAs’ distinct and unique mechanism of enhancing insulin release in response to glucose, increasing satiety, and ...